Literature DB >> 27032892

Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.

Yao Yao1, Junying Wang1, Sei Yoshida1,2, Shigeyuki Nada3, Masato Okada3, Ken Inoki4,5,6.   

Abstract

Aberrant activation of mechanistic target of rapamycin complex 1 (mTORC1) in glomerular podocytes leads to glomerular insufficiency and may contribute to the development of glomerular diseases, including diabetic nephropathy. Thus, an approach for preventing mTORC1 activation may allow circumvention of the onset and progression of mTORC1-dependent podocyte injury and glomerular diseases. mTORC1 activation requires inputs from both growth factors and nutrients that inactivate the tuberous sclerosis complex (TSC), a key suppressor of mTORC1, on the lysosome. Previous studies in mice revealed that the growth factor-phosphatidylinositol 3-kinase pathway and mTORC1 are essential for maintaining normal podocyte function, suggesting that direct inhibition of the phosphatidylinositol 3-kinase pathway or mTORC1 may not be an ideal approach to sustaining physiologic podocyte functions under certain disease conditions. Here, we report the role of the Ragulator complex, which recruits mTORC1 to lysosomes in response to nutrient availability in podocytes. Notably, podocytes lacking Ragulator maintain basal mTORC1 activity. Unlike podocyte-specific mTORC1-knockout mice, mice lacking functional Ragulator in podocytes did not show abnormalities in podocyte or glomerular function. However, aberrant mTORC1 activation induced by active Rheb in podocyte-specific TSC1-knockout (podo-TSC1 KO) mice did require Ragulator. Moreover, ablation of Ragulator in the podocytes of podo-TSC1 KO mice or streptozotocin-induced diabetic mice significantly blocked the development of pathologic renal phenotypes. These observations suggest that the blockade of mTORC1 recruitment to lysosomes may be a useful clinical approach to attenuate aberrant mTORC1 activation under certain disease conditions.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  diabetic glomerulopathy; glomerulopathy; nutrition; podocyte; renal cell biology; signaling

Mesh:

Substances:

Year:  2016        PMID: 27032892      PMCID: PMC5118471          DOI: 10.1681/ASN.2015010032

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

Authors:  P Mundel; J Reiser; A Zúñiga Mejía Borja; H Pavenstädt; G R Davidson; W Kriz; R Zeller
Journal:  Exp Cell Res       Date:  1997-10-10       Impact factor: 3.905

3.  Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.

Authors:  Jian-Kang Chen; Jianchun Chen; Eric G Neilson; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

4.  Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism.

Authors:  L Straathof-Galema; J F M Wetzels; H B P M Dijkman; E J Steenbergen; L B Hilbrands
Journal:  Am J Transplant       Date:  2006-02       Impact factor: 8.086

5.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

6.  Rheb binds and regulates the mTOR kinase.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Kazuyoshi Yonezawa; Joseph Avruch
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

7.  Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

Authors:  Ramon G B Bonegio; Robert Fuhro; Zhiyong Wang; C Robert Valeri; Christopher Andry; David J Salant; Wilfred Lieberthal
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

8.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Authors:  Suchithra Menon; Christian C Dibble; George Talbott; Gerta Hoxhaj; Alexander J Valvezan; Hidenori Takahashi; Lewis C Cantley; Brendan D Manning
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

Review 9.  The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease.

Authors:  Andrey V Cybulsky
Journal:  Kidney Int       Date:  2012-12-19       Impact factor: 10.612

10.  Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.

Authors:  Constantinos Demetriades; Nikolaos Doumpas; Aurelio A Teleman
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

View more
  6 in total

1.  Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity.

Authors:  Yao Yao; Sungki Hong; Takayuki Ikeda; Hiroyuki Mori; Ormond A MacDougald; Shigeyuki Nada; Masato Okada; Ken Inoki
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

Review 2.  New Insights into Podocyte Biology in Glomerular Health and Disease.

Authors:  Suheir Assady; Nicola Wanner; Karl L Skorecki; Tobias B Huber
Journal:  J Am Soc Nephrol       Date:  2017-04-12       Impact factor: 10.121

3.  FOXO1-Mediated Downregulation of RAB27B Leads to Decreased Exosome Secretion in Diabetic Kidneys.

Authors:  Mengru Zeng; Jin Wen; Zhengwei Ma; Li Xiao; Yutao Liu; Sangho Kwon; Yu Liu; Zheng Dong
Journal:  Diabetes       Date:  2021-02-17       Impact factor: 9.337

Review 4.  The Architecture of the Rag GTPase Signaling Network.

Authors:  Raffaele Nicastro; Alessandro Sardu; Nicolas Panchaud; Claudio De Virgilio
Journal:  Biomolecules       Date:  2017-06-30

Review 5.  Effects of High Glucose and Lipotoxicity on Diabetic Podocytes.

Authors:  Ran Nakamichi; Kaori Hayashi; Hiroshi Itoh
Journal:  Nutrients       Date:  2021-01-15       Impact factor: 5.717

Review 6.  Targeting lysosomes in human disease: from basic research to clinical applications.

Authors:  Mengdie Cao; Xiangyuan Luo; Kongming Wu; Xingxing He
Journal:  Signal Transduct Target Ther       Date:  2021-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.